Efficacy and safety of Panax ginseng berry extract on glycemic control: A 12-wk randomized, double-blind, and placebo-controlled clinical trial
Background: Antihyperglycemic effects of Panax ginseng berry have never been explored in humans. The aims of this study were to assess the efficacy and safety of a 12-wk treatment with ginseng berry extract in participants with a fasting glucose level between 100 mg/dL and 140 mg/dL. Methods: This s...
Main Authors: | Han Seok Choi, Sunmi Kim, Min Jung Kim, Myung-Sunny Kim, Juewon Kim, Chan-Woong Park, Daebang Seo, Song Seok Shin, Sang Woo Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-01-01
|
Series: | Journal of Ginseng Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1226845316300306 |
Similar Items
-
Melanogenesis inhibition activity of floralginsenoside A from Panax ginseng berry
by: Dae Young Lee, et al.
Published: (2017-10-01) -
An 8-wk, randomized, double-blind, placebo-controlled clinical trial for the antidiabetic effects of hydrolyzed ginseng extract
by: Soo-Hyun Park, et al.
Published: (2014-10-01) -
Skin wound healing effects of (+)-syringaresinol from ginseng berry
by: Jee-hyun Hwang, et al.
Published: (2023-09-01) -
Panax ginseng
by: Alyaa Majid
Published: (2019-05-01) -
Panax ginseng
by: Alyaa Majid
Published: (2019-05-01)